Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New $24.54 Million Investment in Cardinal Health, Inc. $CAH

Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 119,399 shares of the company’s stock, valued at approximately $24,537,000. Cardinal Health accounts for about 0.9% of Fideuram Intesa Sanpaolo Private Banking S.P.A.’s investment portfolio, making the stock its 21st largest holding.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Integrated Wealth Concepts LLC increased its stake in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Cardinal Health during the second quarter worth approximately $1,935,000. Cerity Partners LLC increased its stake in shares of Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after buying an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC increased its stake in shares of Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after buying an additional 2,646 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.3%

Shares of Cardinal Health stock opened at $200.31 on Wednesday. The firm has a market capitalization of $46.91 billion, a P/E ratio of 30.63, a P/E/G ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The firm’s 50 day moving average is $206.29 and its two-hundred day moving average is $208.61.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CAH. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Morgan Stanley upped their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Argus upped their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. William Blair started coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. Finally, Barclays increased their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.